Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q28361615

about

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee Thiopurine monitoring in children with inflammatory bowel disease: a systematic review The Role of Laboratory Tests in Crohn's Disease Pharmacogenetics in inflammatory bowel disease Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide Thioguanine in inflammatory bowel disease: Long-term efficacy and safety Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.Suspected azathioprine induced liver cirrhosis: an unusual side effect.Review article: acute severe ulcerative colitis - evidence-based consensus statements.Review article: monitoring for drug side-effects in inflammatory bowel disease.Therapeutic drug monitoring in patients with inflammatory bowel disease Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease.Pharmacogenomics and IBD: TPMT and thiopurines.Review article: practical management of inflammatory bowel disease patients taking immunomodulators.Review article: thiopurines in inflammatory bowel disease.Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Medical treatment of ulcerative colitis Current and future treatments of autoimmune hepatitis.Implementation of TPMT testing.Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?Thiopurine therapy in inflammatory bowel disease.Optimizing thiopurine therapy in inflammatory bowel disease.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.The role and advances of immunomodulator therapy for inflammatory bowel disease.Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Maintenance therapy options for ulcerative colitis.Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.TPMT in the treatment of Crohn's disease with azathioprine.Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease.Prediction of 6-thioguanine nucleotides levels in Japanese patients with inflammatory bowel diseases during long-term thiopurine administration.Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel analysis.Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.

P2860

Q22242348-AA3C789C-5F45-4A40-A8DE-2B23DA1E5518 Q26859122-5F6DDDDA-5909-44ED-BA15-0C272F0504FE Q28075045-2AFEBFC7-F1C7-45D4-B1AE-10287F66355B Q28246002-F5C79323-E827-49ED-850A-253D3B730CDA Q28361611-AFDB3C6B-3C0E-407A-877E-1552E68B3271 Q33731976-EF325B2A-F3B2-47D7-8E42-2E896BEED744 Q33876453-9F247C65-E02B-4FD8-AF6F-CEE87CBCBE04 Q34446588-E5F8F486-199A-460D-8B43-40615006BD02 Q34476152-6F4949DE-F26F-49F0-8F8A-E56631B9ED49 Q34528270-096CF49E-2441-4B44-AD86-49B9A4A7F780 Q34585315-A93F1743-0118-4D8F-B39F-FD7DF54EC5B0 Q35140715-60ADFE97-56DB-4A2B-8E2C-031C329595FB Q35596702-D63D51A7-72F4-4A82-8A64-BA9A7A22CD1F Q35787643-3F32D534-243C-42C1-AECF-BCBF7F5878A3 Q36166363-BAE790E9-F458-48FC-82F8-394F6926462F Q36570796-74CEE64A-122F-45BE-880B-A9569EDD4072 Q36631430-934BA4C4-6CF9-48A2-8356-4FE33E224646 Q36822402-CE2B9849-68C0-42EC-9ECF-4967C7A3710D Q37149572-7757AA15-8390-42B1-BD8C-D99AAD1BA594 Q37345896-8048DF67-2495-4791-B035-216BE2C47879 Q37427481-878469B2-929E-4844-9537-1C4C0927B388 Q37503380-33C7C24A-DC24-461B-B13C-F4287F9AC906 Q37678056-976653E1-6D44-4F8A-AF72-887D8382A11D Q37688050-C5DA5EBC-094D-4120-80E6-EFCC794E3E95 Q37798819-FF1D10A9-8777-40E9-9559-B136D0F6C951 Q37800458-8EEB84C0-7484-4910-AF05-D5F88A4E4518 Q38179509-59C39C40-8CF9-4B18-8D76-73CAB1FA89FF Q38237701-6E74E43D-59FB-40A9-B53E-743F767ED00E Q38417177-30F0CB33-BC31-40BB-A0FF-D20E6636044A Q38501680-FC6696F6-AA7C-4156-8E35-CE8574F88934 Q38563075-1BDA8F0E-EB24-43EC-B602-03593EDE6DA9 Q38848140-ECFDF0AF-330C-4223-9068-4E02B932C1F7 Q40551481-1A9FBD91-8679-4252-A03A-04D1C348FE8E Q41762842-493D5BB7-2262-4175-B260-0094469C96DB Q42758200-A8AFF8A4-6C99-40E1-8B02-A2B134524A9C Q43006248-F22640D1-C7CD-4340-B658-D0DDF8E6AE5E Q43159235-8A540029-1EFC-40FC-954D-3AD87FDA8B9F Q43532191-1976BA6E-AB8E-4684-8201-5BB69A94FEF8 Q43699289-14D46674-73FC-4FAE-B9DE-EDD4E26163DD Q44148231-26A01724-FFFD-4C50-A812-CFEBDE45CC20

P2860

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q28361615

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@ast

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@en

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@nl

type

label

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@ast

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@en

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@nl

prefLabel

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@ast

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@en

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@nl

P1433

Q28361615-60E79586-2D2B-4765-AAC5-C57D3D0E96B9

P1476

Q28361615-0B952636-E467-4E71-93AE-5A5B6074C143

P2093

Q28361615-119704F9-D785-40A4-AFB0-F2C50731D510

Q28361615-43060F8B-3128-410D-BD38-AF80C07913ED

Q28361615-81FA7FEB-65DA-498A-94A8-6A44935793F5

Q28361615-A0A9B977-0426-42BF-B531-ACB96E947DC7

Q28361615-A72F7D50-4D1B-48A8-B19E-1D5F77F5D7EE

Q28361615-C144FF78-158B-4B1F-9E8E-040D5EDC31B5

P2860

Q28361615-01B18CD8-0AD1-411C-A47A-60299386A6F5

Q28361615-131F6984-0BF0-47A5-8645-2F40A6A224CC

Q28361615-1AF44B5B-99FB-4F8F-B37C-6EE09F20D353

Q28361615-1DE43F13-3D08-44EE-BC60-EEF56C4548E2

Q28361615-21E6BC92-1CCF-4E01-B0BF-84A1FDBEF8C0

Q28361615-2CBC7D22-167F-4126-BCA0-A259AF42F118

Q28361615-4047097A-E3E2-4FE4-9DA6-49C5DA5B73EA

Q28361615-70822105-DEF4-4E29-90B3-BE309D87378E

Q28361615-91FDF21E-8085-4ABE-A9C3-A83DE0C952BB

Q28361615-942122BF-EB01-4894-8D71-74F77679AC12

P304

Q28361615-F69DC35F-2071-437A-9AB1-F873681959B4

P31

Q28361615-3767782D-5838-4105-AF49-CA9C4BC2C6CB

P3181

Q28361615-5487AB45-44B1-462F-A77E-96D2FAA98AAC

P356

Q28361615-EEF287EF-A420-4A61-B964-F8642F37DE78

P407

Q28361615-BB1A063E-17C9-4A77-A474-511292F14C09

P433

Q28361615-BDE9BFF2-686E-47D0-A4A2-ECC7CD5CCCE5

P478

Q28361615-2C2700B5-3318-4B23-B73A-80E773708862

P50

Q28361615-86561AC6-603F-4CF5-9659-30409BFAFECE

Q28361615-FFF60EBF-DB85-433B-B2CC-5326742CE08C

P577

Q28361615-BFC9C59F-DA29-439D-A1A3-8371A589FE22

P5875

Q28361615-D2B5C1A1-D9B8-44C5-9BB5-17D691ECDFAA

P698

Q28361615-8646C0D7-2E67-4747-A58B-A843F5B26FC3

P921

Q28361615-836D0369-72B0-4570-B20F-7D480C7CC196

Q28361615-9D37EF47-9866-4BCD-970F-C499ED82A7F1

P932

Q28361615-4DC5A605-5E94-4F54-A86D-EA526386100F

P3181

P356

P1433

P1476

Measurement of thiopurine meth ...... ith inflammatory bowel disease

@en

P2093

A L Weaver

http://www.w3.org/2001/XMLSchema#string

C L Franklin

http://www.w3.org/2001/XMLSchema#string

D C Mays

http://www.w3.org/2001/XMLSchema#string

J J Lipsky

http://www.w3.org/2001/XMLSchema#string

M G Pike

http://www.w3.org/2001/XMLSchema#string

P W Lowry

http://www.w3.org/2001/XMLSchema#string

P2860

Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

The clinical pharmacology of 6-mercaptopurine.

A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy.

Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

P304

665-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3991661

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.49.5.665

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

William Jeffery Sandborn

William J. Tremaine

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277446058

http://www.w3.org/2001/XMLSchema#string

P698

11600469

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1728511

http://www.w3.org/2001/XMLSchema#string